Academic literature on the topic 'Fc fragment'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Fc fragment.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Fc fragment"
Stone, G. C., U. Sjöbring, L. Björck, J. Sjöquist, C. V. Barber, and F. A. Nardella. "The Fc binding site for streptococcal protein G is in the C gamma 2-C gamma 3 interface region of IgG and is related to the sites that bind staphylococcal protein A and human rheumatoid factors." Journal of Immunology 143, no. 2 (July 15, 1989): 565–70. http://dx.doi.org/10.4049/jimmunol.143.2.565.
Full textDiamond, B., L. Boccumini, and B. K. Birshtein. "Site of binding of IgG2b and IgG2a by mouse macrophage Fc receptors by using cyanogen bromide fragments." Journal of Immunology 134, no. 2 (February 1, 1985): 1080–83. http://dx.doi.org/10.4049/jimmunol.134.2.1080.
Full textLee, B. W., C. F. Simmons, T. Wileman, and R. S. Geha. "Intracellular cleavage of newly synthesized low affinity Fc epsilon receptor (Fc epsilon R2) provides a second pathway for the generation of the 28-kDa soluble Fc epsilon R2 fragment." Journal of Immunology 142, no. 5 (March 1, 1989): 1614–20. http://dx.doi.org/10.4049/jimmunol.142.5.1614.
Full textWillis, H. E., B. Browder, A. J. Feister, T. Mohanakumar, and S. Ruddy. "Monoclonal antibody to human IgG Fc receptors. Cross-linking of receptors induces lysosomal enzyme release and superoxide generation by neutrophils." Journal of Immunology 140, no. 1 (January 1, 1988): 234–39. http://dx.doi.org/10.4049/jimmunol.140.1.234.
Full textdi Tommaso, Anne, Matthieu O. Juste, Zineb Lakhrif, Marie-Noëlle Mévélec, Coraline Borowczyk, Pierre Hammeni, Guillaume Désoubeaux, et al. "Engineering and Functional Evaluation of Neutralizing Antibody Fragments Against Congenital Toxoplasmosis." Journal of Infectious Diseases 224, no. 4 (August 7, 2021): 705–14. http://dx.doi.org/10.1093/infdis/jiab141.
Full textCarosella, E. D., A. B. Tilden, and N. E. Dunlap. "Human B cell differentiation by Fc fragment." Cellular Immunology 121, no. 2 (July 1989): 269–79. http://dx.doi.org/10.1016/0008-8749(89)90025-7.
Full textCoe, Alexander P. F., Janet A. Askari, Adam D. Kline, Martyn K. Robinson, Hishani Kirby, Paul E. Stephens, and Martin J. Humphries. "Generation of a Minimal α5β1Integrin-Fc Fragment." Journal of Biological Chemistry 276, no. 38 (June 1, 2001): 35854–66. http://dx.doi.org/10.1074/jbc.m103639200.
Full textKim, Eunhee G., Jieun Jeong, Junghyeon Lee, Hyeryeon Jung, Minho Kim, Yi Zhao, Eugene C. Yi, and Kristine M. Kim. "Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment–Drug Conjugates." Biomolecules 10, no. 6 (June 25, 2020): 955. http://dx.doi.org/10.3390/biom10060955.
Full textMorgan, E. L., M. V. Hobbs, and W. O. Weigle. "Lymphocyte activation by the Fc region of immunoglobulin. I. Role of prostaglandins in the down regulation of Fc fragment-induced polyclonal antibody production." Journal of Immunology 134, no. 4 (April 1, 1985): 2247–53. http://dx.doi.org/10.4049/jimmunol.134.4.2247.
Full textGallagher, D. Travis, Connor V. Galvin, and Ioannis Karageorgos. "Structure of the Fc fragment of the NIST reference antibody RM8671." Acta Crystallographica Section F Structural Biology Communications 74, no. 9 (August 29, 2018): 524–29. http://dx.doi.org/10.1107/s2053230x18009834.
Full textDissertations / Theses on the topic "Fc fragment"
D'ACREMONT, GEFFRIER CHRISTINE. "Recepteur de faible affinite pour le fragment fc des immunoglobulines g (recepteur fc gamma de type iii) : mise en evidence de la forme soluble circulante dans le plasma humain." Nantes, 1989. http://www.theses.fr/1989NANT030M.
Full textChichehian, Behrouz. "Formes solubles et membranaires des récepteurs du fragment Fc des IgG chez l'homme." Montpellier 1, 1987. http://www.theses.fr/1987MON13510.
Full textBenhamou, Marc. "Etude des recepteurs fc des mastocytes derives de la moelle osseuse de souris : modulation du fc::(e)r1 par la dexametasone, et caracterisation du fc::(g)r." Paris 7, 1988. http://www.theses.fr/1988PA077009.
Full textBas, Mathilde. "N-glycosylation du fragment Fc : impact sur les fonctions effectrices des anticorps et sur leur pathogénicité dans l'auto-immunité du système nerveux central." Thesis, Lille 2, 2018. http://www.theses.fr/2018LIL2S055.
Full textThe crystallizable fragment (Fc) of immunoglobulins G (IgG) orchestrates their function by binding to Fc-receptors (FcRs) and complement. N-glycosylation of asparagine-297 (N297) located in the Fc domain modifies this binding affinity endowing antibodies to selectively engage functionally distinct FcRs. Here we studied the impact of Fc N-glycosylation on antibody effector functions and on their pathogenicity in central nervous system (CNS) auto-immunity.The longevity of antibodies in the blood circulation is essentially dependent on binding to the neonatal FcR (FcRn) that salvages antibodies from degradation. Fc N-glycosylation is generally excluded to impact on antibody serum persistence. Fc-sialylation might provide an exception as our results demonstrate that Fc-sialylation of antibodies enhances their persistence in the blood circulation. This polarized glycosylation is achieved using an Fc mutation, a glutamate-residue deletion at a position close to N297 in the human IgG1 sequence. The sialylated deleted antibody is also characterized by a loss of its effector functions in vitro through a reduced binding to pro-inflammatory FcRs and complement.We studied the impact of Fc N-glycosylation on the pathogenicity of myelin-reactive auto-antibodies that can be detected in multiple sclerosis and neuromyelitis optica. We cloned a pathogenic monoclonal antibody that is specific for MOG (Myelin oligodendrocyte glycoprotein) and we obtained glycovariants of this murine IgG1 by Fc-engineering and/or production in distinct cell-lines. Assessment of their pathogenicity in murine models of EAE (Experimental auto-immune encephalomyelitis) allowed identification of notable variants. First, producing the anti-MOG antibody in a hypofucosylating cell-line augments its pathogenicity in EAE. Second, introducing specific amino-acid mutations in the Fc of the anti-MOG antibody, known to impact N-glycosylation, results in a loss of its pathogenicity and even a reduced severity of induced EAE. Such a difference in the variants pathogenicity might be explained by distinct FcR-binding profiles.This study demonstrates the major potential of Fc N-glycosylation to dictate the pathogenicity of a myelin reactive antibody response during auto-immune diseases of the CNS
Aloulou, Meryem. "La double face du signal ITAM inhibiteur (ITAMi) du système immunitaire : de la protection à l'agression." Paris 7, 2010. http://www.theses.fr/2010PA077088.
Full textImmune homeostasis is regulated by a finely tuned network of positive and negative regulatory mechanisms. These events guarantee proper surveillance and prevent hyperactivity which could lead otherwise to autoimmunity and inflammatory diseases. Immune responses involve the stimulation of immunoreceptors that contain tyrosine-based activation motifs (ITAMs). One arm of control involves immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors, which, upon co-aggregation, initiate an inhibitory signal through recruitment of signal-aborting phosphatases. In this study, we have challenged the classical concept of ITAM-ITIM by highlighting the inhibitory properties of the ITAM bearing receptors FcvRIII and FcaRI. We have termed this new configuration of the ITAM, ITAMi for inhibitory ITAM (Article 3). We have shown that the type of ligand and its valency were key elaments of thé cellular response induced by both receptors. ITAMi signaling induced by RFcvlll has deleterious role during seps/s (Article 2). In contrast, ITAMi signaling may also have beneficial effects in some inflammatory or autoimmune diseases (Articles 1 and 4). ITAMi signaling induced by FcyRIII and FcaRI can inhibit signal induced by a whole variety of other receptors (such as FceRI, TLR4, MRCO, TNFaR) in thé absence of co-aggregation. Nevertheless, our results show that both receptors (effector and target) are found in the same polarized intracellular clusters named "inhibosome" whose formation is required for providing ITAMi signaling (Article 5)
Lin, Hsin Hsin. "Mechanisms of Intravenous Immunoglobulin in the Treatment of Experimental Autoimmune Neuritis." University of Sydney, 2007. http://hdl.handle.net/2123/1696.
Full textThe aims of this study were to test the efficacy of immunoglobulin and its Fab and Fc fragment in the treatment of experimental autoimmune neuritis (EAN) in Lewis rats, to investigate which portion of immunoglobulin is operative in the effect of IVIg, and to clarify the possible mechanisms by which immunoglobulin exerts its action in the treatment of rats EAN. EAN was induced by immunization with whole bovine peripheral nerve myelin. The immunized rats were randomized into groups, assessed clinically, electrophysiologically, and histologically, and intravenously injected with normal saline, albumin, human IVIg preparation, purified Fab or Fc fragments. The treatment efficacy was compared between normal saline and albumin groups, albumin and IVIg groups, albumin and Fab groups, albumin and Fc groups, Fab and Fc groups, Fab and IVIg groups, and Fc and IVIg groups. Methods of myelin isolation, antibody purification, and Western blot techniques were also applied. The results revealed that treatment with Fc fragment and IVIg at the onset of signs of disease effectively prevented further progression of disease, shortened disease duration, and facilitating recovery from illness as shown in clinical, electrophysiological and histological parameters. In the study which the efficacy of albumin and IVIg was compared, 5 out of 17 rats (29%) in the albumin group and 12 out of 17 (71%) in the IVIg group completely recovered from the clinical disease by day 30. The animals receiving IVIg treatment exhibited lower clinical scores, less prolongation of S wave latencies, better maintained S wave amplitudes, less reduction of distal motor NCVs, better maintained distal and proximal CMAP amplitudes, and lower histological grades. In the study which the efficacy of albumin, Fab fragment, Fc fragment, and IVIg was compared, 0 out of 8 (0%) in the albumin group, 1 out of 8 (13%) in the Fab group, 4 out of 8 (50%) in the Fc group, and 6 out of 9 (67%) rats in the IgG group completely recovered from the clinical disease by day 30. The animals receiving Fc fragment and IVIg treatment exhibited lower clinical scores, less prominent weight loss, less prolongation of S wave latencies, better maintained S wave amplitudes, less reduction of distal motor NCVs, better maintained distal and proximal CMAP amplitudes, and lower histological grades.
Lin, Hsin Hsin. "Mechanisms of Intravenous Immunoglobulin in the Treatment of Experimental Autoimmune Neuritis." Thesis, The University of Sydney, 2006. http://hdl.handle.net/2123/1696.
Full textDurand, Véronique. "Etude du rôle des récepteurs de type III pour le Fc des IgG : effets regulateurs des auto-anticorps correspondants dans l'auto-immunité (doctorat : immunologie)." Brest, 2000. http://www.theses.fr/2000BRES3100.
Full textKrämer, Thomas [Verfasser]. "Prävention der ischämischen Querschnittlähmung durch ein carbamyliertes Fusionsprotein aus Erythropoetin und einem humanen Fc-Fragment bei Aortenokklusion am Schweinemodell / Thomas Krämer." Ulm : Universität Ulm. Medizinische Fakultät, 2013. http://d-nb.info/1030045658/34.
Full textSchlaeth, Martin [Verfasser]. "Untersuchung der Antikörper-abhängigen zellulären Zytotoxizität von humanisierten EGF-Rezeptor-Antikörpern mit optimiertem Antikörper-Fc-Fragment gegen Tumorzellen mit mutiertem KRAS-Protein / Martin Schlaeth." Kiel : Universitätsbibliothek Kiel, 2013. http://d-nb.info/1031190244/34.
Full textBook chapters on the topic "Fc fragment"
Gooch, Jan W. "Fc Fragment." In Encyclopedic Dictionary of Polymers, 892. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-6247-8_13740.
Full textBereli, Nilay, Handan Yavuz, and Adil Denizli. "Oriented Immobilized Anti-hIgG via Fc Fragment-Imprinted Cryogels." In Encyclopedia of Membranes, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-40872-4_732-1.
Full textBereli, Nilay, Handan Yavuz, and Adil Denizli. "Oriented Immobilized Anti-hIgG via Fc Fragment-Imprinted Cryogels." In Encyclopedia of Membranes, 1435–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-44324-8_732.
Full textRenz, H., and B. Gierten. "Fc-Fragmente." In Lexikon der Medizinischen Laboratoriumsdiagnostik, 1. Berlin, Heidelberg: Springer Berlin Heidelberg, 2017. http://dx.doi.org/10.1007/978-3-662-49054-9_1092-1.
Full textRenz, H., and B. Gierten. "Fc-Fragmente." In Springer Reference Medizin, 845. Berlin, Heidelberg: Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1092.
Full textBlundell, Patricia, and Richard Pleass. "A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors." In Methods in Molecular Biology, 417–21. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8958-4_20.
Full textBereli, Nilay, Handan Yavuz, and Adil Denizli. "Affinity Separation and Crystallization of Fc Fragments." In Encyclopedia of Membranes, 1–2. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-642-40872-4_690-1.
Full textBereli, Nilay, Handan Yavuz, and Adil Denizli. "Affinity Separation and Crystallization of Fc Fragments." In Encyclopedia of Membranes, 22–23. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-44324-8_690.
Full textSádio, Flávio, Gerhard Stadlmayr, Katharina Stadlbauer, Florian Rüker, and Gordana Wozniak-Knopp. "Yeast Surface Display and Cell Sorting of Antigen-Binding Fc Fragments." In Methods in Molecular Biology, 287–308. New York, NY: Springer New York, 2019. http://dx.doi.org/10.1007/978-1-4939-9024-5_13.
Full textSondermann, Peter. "Crystal Structures of Human IgG-Fc Fragments and Their Complexes with Fcγ Receptors." In Molecular and Cellular Mechanisms of Antibody Activity, 61–83. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7107-3_3.
Full textConference papers on the topic "Fc fragment"
Kuroda, Taihei, Yutaka Abe, Akiko Kaneko, Iwasawa Yuzuru, Hideki Nariai, Hiroshi Sakaba, Kazuya Koyama, and Eiji Matsuo. "Estimation of Fragmentation on Jet Breakup in Coolant." In 2012 20th International Conference on Nuclear Engineering and the ASME 2012 Power Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/icone20-power2012-54399.
Full textReed, Charles, Vernon Dailey, Anissa Elayadi, Lindsay Williams, Dina Schneider, Thomas Reed, Jonathan Lewis, Richard Einstein, and Samuel Broder. "Abstract B247: Integration of a modularized protein engineering technology and the RheoSwitch Therapeutic System® platform to develop high affinity trastuzumab single chain variable fragment-Fc proteins for gene therapy applications." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-b247.
Full textPereira, J., C. Cretney, and R. H. Aster. "VARIABLE EXPRESSION OF ALLOANTIGENS IN PLATELET COHORTS OF DIFFERENT MEAN DENSITY:AN EFFECT OF AGING IN VIVO." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644158.
Full textMohamedali, Khalid A., Lawrence H. Cheung, Ana Alvarez-Cienfuegos, and Michael G. Rosenblum. "Abstract 2396: Development of a new generation of dimeric, highly cytotoxic fusion proteins containing active GrB and VEGF targeting tumor neovasculature: Incorporating IgG heavy chain Fc fragments improves cytotoxicity, stability and pharmacokinetics." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-2396.
Full textMohamedali, Khalid A., Lawrence H. Cheung, Ana Alvarez-Cienfuegos, and Michael G. Rosenblum. "Abstract 2396: Development of a new generation of dimeric, highly cytotoxic fusion proteins containing active GrB and VEGF targeting tumor neovasculature: Incorporating IgG heavy chain Fc fragments improves cytotoxicity, stability and pharmacokinetics." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-2396.
Full textUchiyama, Yuta, Yutaka Abe, Akiko Fujiwara, Hideki Nariai, Eiji Matsuo, Keiko Chitose, Kazuya Koyama, and Kazuhiro Itoh. "Visual Observation of Fragmentation Behavior on Molten Material Jet Surface in Coolant." In 16th International Conference on Nuclear Engineering. ASMEDC, 2008. http://dx.doi.org/10.1115/icone16-48359.
Full textModderman, P. W., J. G. Huisman, J. A. van Mourik, A. E. G. Kr, and v. d. Borne. "PLATELET ACTIVATION INDUCED BY A MONOCLONAL ANTIBODY AGAINST THE PLATELET GP Ilb/IIIa COMPLEX." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643514.
Full textvan Dinther, T. G., F. Hol, and D. G. Meuleman. "EFFECT OF VARIOUS HEPARIN(OID)S ON HEPARIN COFACTOR II MEDIATED ANTI-THROMBIN ACTIVITY AND INHIBITION OF THROMBIN GENERATION IN VITRO." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644353.
Full textUchiyama, Yuta, Yutaka Abe, Akiko Kaneko, Hideki Nariai, Makoto Yamagishi, Eiji Matsuo, Kazuya Koyama, and Kazuhiro Itoh. "Experimental Study on Influence of Interfacial Behavior on Jet Surface Fragmentation." In 17th International Conference on Nuclear Engineering. ASMEDC, 2009. http://dx.doi.org/10.1115/icone17-75307.
Full text